XENETIC BIOSCIENCES, INC. (XBIO)

Every figure this model derived for XBIO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2018-12-31
cash 6,471,766 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 6,654,077 AssetsCurrent 2026-06-30
current liabilities 894,977 LiabilitiesCurrent 2026-06-30
equity 6,073,021 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2026-06-30
ocf -2,312,795 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,260,777 Revenues 2026-06-30
sbc 93,129 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up XBIO on one particular measure came for.

RatioValue
cash operating margin-78.15
current ratio7.43
current ratio reported7.43
dilution pct10.4
fcf margin-70.93
growth cv1.04
operating margin-81.01
owner earnings margin-73.78
revenue growth33.3
revenue growth per share20.74
rule of 40-47.71
sbc pct revenue2.86

What to be careful about

What this model itself distrusts about XBIO's figures. Written by the derivation as it ran, not added afterwards.